Project Grant R61AT012270
Award Date
9/12/24
Completion Date
8/31/26
Dollars Obligated
$1.7M
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Awarding Federal Agency
National Center for Complementary and Integrative Health
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded Weill Medical College of Cornell University a $666,530 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to develop an accessible MRI-based method for mapping the cerebral metabolic rate of oxygen (CMRO2) in acute ischemic stroke patients. The objective is to validate this MRI-based CMRO2 approach against the current standard of 15O PET imaging, and compare it...
This $2,280,771 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop novel imaging biomarkers for diagnosing and characterizing myofascial trigger points in myofascial pain syndrome. The key products and services to be delivered include:
Developing clinically-translatable PET-MRI imaging techniques to assess disease mechanisms and pain indicators associated with...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to advance the understanding and treatment of Parkinson's disease (PD). The $684,451 award to the Weill Medical College of Cornell University aims to:
Identify PD progression subtypes through integrative modeling of longitudinal clinical, transcriptomic, and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will provide $694,369 to Weill Medical College of Cornell University to conduct a multi-scale, multi-modal longitudinal study examining the neural mechanisms underlying cognitive decline in multiple sclerosis (MS).
The study aims to utilize advanced MRI and PET imaging techniques to...
This $4.7 million project grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke will support the development of electrophysiological and ultrasound quantitative biomarkers for myofascial pain syndrome. The grant to Beth Israel Deaconess Medical Center will establish the use of electrical impedance myography, myofiber threshold tracking excitability testing, and ultrasound shear wave elastography to assess differences between patients with...
This $353,942 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research to develop quantitative MRI biomarkers for characterizing and monitoring multiple sclerosis (MS).
The key objectives are to: 1) curate a database of normative reference standard model imaging (SMI) parameters from diffusion MRI data in healthy and MS patients, 2) develop...
This $9,237,770 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to gain integrated mechanistic insights into biological processes that contribute to chronic postsurgical pain (CPSP) and understand how these processes relate to CPSP heterogeneity. The primary research activities include:
Characterizing peripheral neural and immune mechanisms contributing to CPSP in 220...
This $1,133,250 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports research into the mechanisms underlying motor superperformance. The award funds investigations at Weill Medical College of Cornell University to identify and characterize genetic mutations that can enhance motor function in mice, with the goal of understanding how these...
This $541,109 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports a clinical study to quantify myelin loss and recovery in ischemic stroke patients. The key products and services to be delivered under this five-year grant include:
Demonstrating the feasibility of using a novel quantitative magnetic resonance imaging (MRI)...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (part of the U.S. Department of Health and Human Services), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,314,276 to Emory University to develop and test new methods for selectively and accurately measuring nociceptive (pain) sensitivity and the brain's response to nociceptive stimuli in both healthy individuals and those with the chronic pain condition...